Foundation Fighting Blindness Clinical Research Institute Logo
About Us NavigationGovernance NavigationFunded Projects NavigationClinical Trials NavigationSymposium NavigationRelated Links NavigationContact Us Navigation
 

Mission Statement:
The mission of the Foundation Fighting Blindness Clinical Research Institute is to accelerate the translation of laboratory based research into clinical trials for treatments and cures of retinal degenerative diseases.


Background of the FFB Clinical Research Institute:
The Clinical Research Institute is a newly established non-profit entity, a support organization of the Foundation Fighting Blindness (FFB). The mission of the FFB Clinical Research Institute is to accelerate the translation of laboratory based research into clinical trials for treatments and cures of retinal degenerative diseases. It is a medical research institute that will obtain support from government agencies, corporations and private foundations. It may also receive royalties or licensing fees from the drug discovery processes and commercialization of new therapies.

The Foundation Fighting Blindness is a non-profit health foundation that has been incorporated since 1971. Over the years FFB has invested over 140 million dollars to provide seed money for scientific research of diseases of the retina causing blindness.


Goals of the Clinical Research Institute:
The goal of the Clinical Research Institute is to develop a bridge between scientific, clinical, governmental, pharmaceutical and financial communities to advance clinical trials of candidate pharmaceutical and genetic therapies and delivery systems for orphan retinal degenerative diseases (RDD’s). In this regard, the Institute wishes to educate the scientific and clinical communities of opportunities and processes of drug discovery.

As a medical research institute, the FFB Clinical Research Institute will search for candidate therapies and explore new pathogenetic pathways of retinal diseases to further the drug discovery process.

The Institute will raise funds to support Phase I and Phase II clinical trials in order to expedite the commercialization of candidate therapies for RDD patients. The Institute will also provide assistance to the management of clinical trials and subsequent commercialization.

Executive Summary of Symposium

 
The FFB Clinical Research Institute is a Support Organization of the Foundation Fighting Blindness